Aspiriant LLC
ABEV icon

Aspiriant LLC’s Ambev ABEV Stock Holding History

Aspiriant LLC’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$73K Hold
25,000
– – ﹤0.01% 421
2026
Q2 		$78.5K Hold
25,000
– – ﹤0.01% 398
2026
Q1 		$73K Sell
25,000
-148
-0.6% -$423 ﹤0.01% 337
2025
Q4 		$62.1K Buy
25,148
+148
+0.6% +$352 ﹤0.01% 319
2025
Q3 		$55.8K Sell
25,000
-1,603
-6% -$3.67K ﹤0.01% 297
2025
Q2 		$64.1K Buy
26,603
+101
+0.4% +$246 ﹤0.01% 309
2025
Q1 		$61.8K Sell
26,502
-7,133
-21% -$14.3K ﹤0.01% 288
2024
Q4 		$62.2K Buy
33,635
+8,547
+34% +$18.9K ﹤0.01% 288
2024
Q3 		$61.2K Buy
+25,088
New +$56.3K ﹤0.01% 290

Other funds holding ABEV

RWC Asset Management
RWC Asset Management London, United Kingdom $2.7B AUM 20.82% 1-Year Est. Return
Formuepleje A/S
Formuepleje A/S Aarhus C, Denmark $1.21B AUM 21.62% 1-Year Est. Return
Foundation Resource Management
Foundation Resource Management Little Rock, Arkansas $939M AUM 37.7% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
Barings
Barings Charlotte, North Carolina $5.84B AUM 11.61% 1-Year Est. Return
Burford Brothers
Burford Brothers Dallas, Texas $275M AUM 18.76% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Ted Buchan & Co
Ted Buchan & Co San Diego, California $303M AUM 15.07% 1-Year Est. Return

Aspiriant LLC's ABEV Position: Q3 2026 in Review

Aspiriant LLC held its Ambev (ABEV) position steady in Q3 2026 at 25,000 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

Aspiriant LLC first reported a position in ABEV in Q3 2024 and has held it in 9 quarters since. The position peaked at $78.5K in Q2 2026. 83 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Aspiriant LLC held 25,000 shares of Ambev worth $73K as of Q3 2026.
  • Aspiriant LLC left its Ambev share count unchanged in Q3 2026.
  • Ambev made up ﹤0.01% of Aspiriant LLC's portfolio in Q3 2026, its #421 holding.
  • Aspiriant LLC first reported a position in Ambev in Q3 2024 and has held it in 9 quarters since.
  • Aspiriant LLC's Ambev position peaked at $78.5K in Q2 2026.
  • 83 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.